Skip to content

The effect of laser therapy on the healing of human palatal wound after free gingival graft surgery

Effects of Ga Al As 940nm low-level laser therapy on the healing of human palatal mocusa after free gingival graft surgery:a clinical trial study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017092036203N2
Enrollment
16
Registered
2017-11-01
Start date
2017-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palatal wound after free gingival graft surgery. Other and unspecified lesions of oral mucosa

Interventions

Intervention 1: The patients allocated for the test group will receive the following protocol for laser application: A GaAlAs laser will be used for irradiation at a wavelength of 940 nm, an intensity
Biolase Technology Inc., Irvine,CA, USA). The wounds of each experimental group receive laser stimulation at doses of 5J/cm2. The power output is maintained at a constant 0.21 W in the continuous-wave
The spot size is 1.26 cm2, the total energy dose per session is 6.3 J, and powerdensity is 0.16 W/cm2. Laser energy will be applied via a 400 micron optical fiber. The optical fiber is positioned at a
Rehabilitation
Placebo
The patients allocated for the test group will receive the following protocol for laser application: A GaAlAs laser will be used for irradiation at a wavelength of 940 nm, an intensity that had been
The patients allocated to the control group will receive sham irradiation. For this, rubber protection is placed at the tip of the laser device, which don't allow the light to reach the tissue. Th

Sponsors

Private
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patents aged between 20 and 70 years old, systemically healthy, keratinized tissue width<1mm , Full Mouth Plaque Score (FMPS)<20%, Full Mouth Bleeding Score (FMBS)<20%, absence of pathological or morphological alterations in the palatal region (donor site). Exclusion criteria: presence of gag reflex, smoking, presence of proximal bone loss, loss of sensation in palatal mucosa, tooth mobility and/or occlusal trauma in corresponding area, excessive forces (e.g., mechanical forces from orthodontics and traumatic occlusions), systematic diseases that would contraindicate periodontal surgery or interfere with tissue healing such as diabetes, chronic high dose steroid therapy, history of radiation or immuno-suppressive therapy, pregnancy, lactation, gastro-intestinal problems, hyper sensitivity to impression materials, history of drug therapies that are known to interfere with healing or cause gingival enlargement, and patients not complying with postoperative protocols and/or attending their visits irregularly.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Remaining Wound Area. Timepoint: On the day of surgery and on the 7th , 14th, 28th, 60th days after surgery. Method of measurement: Image J software (mm2).

Secondary

MeasureTime frame
Pain. Timepoint: The first 10 days after surgery. Method of measurement: Questionaire (VAS).;Epithelialization. Timepoint: On the 7th , 14th, 28th, 60th days after surgery. Method of measurement: By means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface (total, partial or none).;Secondary bleeding. Timepoint: The first 10 days after surgery. Method of measurement: Questionaire.;Colour Match (brightness parameters). Timepoint: On the 7th , 14th, 28th, 60th days after surgery. Method of measurement: Adobe photoshop software.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhazal Morshedzade Tehrani

Dentistry Faculty of Tehran University of Medical Sciences

ghzlmt@gmail.com+98 21 8888 3575

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 18, 2026